Blog
RSS FeedPosted by Michael Wonder on 18 Jul 2022
DiRx launches groundbreaking annual savings plan: unlimited prescriptions and refills for more than 1,000 generic medications for one annual fee
18 July 2022 - DiRx, an online pharmacy eliminating barriers to medicine affordability and accessibility, today launched its two-tiered Annual ...
Posted by Michael Wonder on 17 Jul 2022
Prescription medication prices to rise
15 July 2022 - The price of nearly 900 prescription medications will rise by as much as $7 on October ...
Posted by Michael Wonder on 05 Jul 2022
Sandoz Canada expands its generics portfolio with three new products
5 July 2022 - Generic medicines like these three products help make effective medicine more affordable and accessible for Canadians and ...
Posted by Michael Wonder on 09 Jun 2022
Lupin receives tentative approval from U.S. FDA for ivacaftor tablets
8 June 2022 - Lupin today announced that it has received tentative approval from the United States FDA for its ...
Posted by Michael Wonder on 16 May 2022
Sun Pharma announces US FDA approval for generic mesalamine extended release capsules
12 May 2022 - Sun Pharmaceutical Industries today announced that it has received final approval from U.S. FDA for its ...
Posted by Michael Wonder on 11 Apr 2022
Eton Pharmaceuticals announces FDA approval of cysteine hydrochloride injection
11 April 2022 - Eton Pharmaceuticals today announced that it has received final approval from the U.S. FDA for its cysteine ...
Posted by Michael Wonder on 10 Apr 2022
Amphastar receives FDA approval for ganirelix acetate injection
8 April 2022 - Amphastar Pharmaceuticals announced that the U.S. FDA has approved the Company's abbreviated new drug application for ganirelix ...
Posted by Michael Wonder on 05 Apr 2022
Curium announces FDA approval of a generic version of DaTscan (Ioflupane I 123 injection) in the U.S.
5 April 2022 - Curium announced today that its generic version of DaTscan (Ioflupane I 123 injection) was approved on 30 ...
Posted by Michael Wonder on 21 Mar 2022
New Australian agency to accelerate genomic research and drive innovation in health care
21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...
Posted by Michael Wonder on 15 Mar 2022
FDA approves first generic of Symbicort to treat asthma and COPD
15 March 2022 - Agency supports development of complex generic drug-device combination product to improve competition and access to more affordable ...
Posted by Michael Wonder on 07 Mar 2022
Teva announces launch of a first generic version of Revlimid (lenalidomide capsules) in the U.S.
7 March 2022 - Teva Pharmaceuticals announced today the launch of a first generic version of Revlimid (lenalidomide capsules), in 5 ...
Posted by Michael Wonder on 04 Mar 2022
Approved first generic for Apokyn injection cartridges requires separately packaged pen
24 February 2022 - The U.S. FDA has approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to ...
Posted by Michael Wonder on 18 Feb 2022
Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
18 February 2022 - Cost savings from Lenalidomide Sandoz can expand treatment options for patients with haemato-oncology conditions. ...
Posted by Michael Wonder on 15 Feb 2022
Office of Generic Drugs 2021 Annual Report
14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...
Posted by Michael Wonder on 02 Feb 2022
FDA approves first generic of Restasis
2 February 2022 - The U.S. FDA has approved the first generic of Restasis (cyclosporin ophthalmic emulsion) 0.05% single use vials ...